Full Text View
Tabular View
No Study Results Posted
Related Studies
MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
This study has been completed.
Study NCT01497223   Information provided by MethylGene Inc.

First Received on December 20, 2011.   Last Updated on April 2, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vulvovaginal Candidiasis
Additional conditions recognized in this trial
Candidiasis
Candidiasis, Vulvovaginal
More general conditions related to this trial
Genital Diseases, Female
Mycoses
Vaginal Diseases
Vaginitis
Vulvar Diseases
Vulvitis
Vulvovaginitis
Interventions listed in this trial
MGCD290
Additional drug interventions recognized in this trial
Fluconazole
More general drug interventions related to this trial
14-alpha Demethylase Inhibitors
Anti-Infective Agents
Antifungal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
MethylGene Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services